Ciaruffoli Robert J. 4

What Happened Robert J. Ciaruffoli, a director of Medicus Pharma Ltd. (MDCX), was granted 25,000 shares on 2026-03-30. The Form 4 reports this as an acquisition via award (transaction code A) at $0.00 per share (total reported consideration $0). This is an equity award/derivative acquisition (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-03-30; Form 4 filed: 2026-04-01 (appears timely).
• Transaction type/code: Grant/award (A); derivative security reported.
• Shares awarded: 25,000; reported price: $0.00 per share; reported total value: $0.
• Shares owned after transaction: Not specified in the provided data.
• Notable footnotes/conditions: None provided in the excerpt (vesting, tax withholding, or plan details not shown).

Context An "A" grant typically reflects a compensation or director equity award (e.g., restricted stock or RSUs) rather than a market purchase—$0.00 indicates no cash was paid at grant, not that the award has no economic value. Such awards may vest over time and can have tax implications when they vest or are settled. This filing is informational about insider compensation and does not by itself indicate buying or selling pressure.